Axys Pharmaceuticals Inc., of South San Francisco, named Jackie Walling vice president of clinical oncology and Douglas Altschuler vice president and general counsel

and added Eliel Bayever, William Freimuth and Ann Wang to its clinical development group...Keryx Biopharmaceuticals Inc., of Jerusalem and Boston, appointed Ron Bentsur head of investor relations

AVI BioPharma Inc. , of Portland, Ore., hired David Mason as its senior vice president of clinical development and regulatory affairs...It also appointed John Skolas chief financial officer and corporate vice president, Jean-Marie Vallet president of human health care and corporate vice president, and Martin Reese director of informatics discovery

ICOS Corp., of Bothell, Wash., added Michael Stewart as vice president of clinical affairs...Also, David Sherris was promoted to vice president of research and development

Iomed Inc., of Salt Lake City, appointed James Laufenberg vice president of sales and marketing, Michael Busch vice president of clinical and regulatory affairs, and Greg Fisher vice president of clinical and commercial development of its product IontoDex

AnorMED Inc., of Vancouver, British Columbia, named Gary Calandra vice president of clinical development

Variagenics Inc., of Cambridge, Mass., named Alan C. Houston chief medical officer and vice president of clinical development

and James Moose senior vice president and general manager of plasma operations...and current president and CEO of Hyseq Inc., and Edward Penhoet, former president and CEO of Chiron Corp

Inhibitex Inc., of Alpharetta, Ga., named Juan Walterspiel vice president of clinical and regulatory affairs...and Arnold Freedman, of the Dana-Farber Cancer Institute in Boston...and named James O'Connell vice president of business development

King Pharmaceuticals Inc., of Bristol, Tenn., named Michael Jolly executive vice president of clinical research and development...Pharma Mar SA, of Madrid, Spain, named Immaculada Abella and Jose Sanchez-Puelles heads of marketing and discovery

and Wayne Hockmeyer, chairman and CEO of MedImmune Inc...EluSys Therapeutics Inc., of Pine Brook, N.J., appointed Linda Nardone vice president of clinical and regulatory affairs

and Florence Wambugu, director of the International Service for the Acquisition of Agri-biotech Applications in Nairobi, Kenya...Immunex Corp., of Seattle, named Mark Booth senior vice president and general manager for Enbrel, and Richard Stead vice president clinical development

Photogen Technologies Inc., of Knoxville, Tenn., named David Shaw vice president of clinical research and technology development...He is a former president, chairman and CEO of Scios Inc

Abgenix Inc., of Fremont, Calif., named Gisela Schwab vice president of clinical development...Gliatech Inc., of Cleveland, named John Redmond president and chief operating officer

The company also named Charles Bergeron, chief financial officer, interim president. • Genentech Inc., of South San Francisco, promoted Daniel Sulzbach to vice president, information resources. • Ilex Oncology Inc., of San Antonio, Texas, named Al Jecminek vice president of business development and intellectual property counsel. • InterMune Pharmaceuticals Inc., of Palo Alto, Calif., hired Nzeera Virani-Ketter as vice president of clinical research. • Memory Pharmaceuticals Corp., of New

Ancile Pharmaceuticals Inc., of San Diego, named Janice Thompson president and chief executive officer...Genetronics Biomedical Ltd., of San Diego, appointed Martin Nash president and chief executive officer...Osteotech Inc., of Eatontown, N.J., named Arthur Alfaro president and chief operating officer

Stephen Fodor will remain CEO and also will become chairman...and Thomas Pekich, senior vice president, global business groups...Techniclone Corp., of Tustin, Calif., named Terrence Chew vice president clinical and regulatory affairs

and Henrik Rasmussen, vice president of clinical and regulatory affairs. • ImmunoGen Inc., of Norwood, Mass., appointed Pauline Ryan senior director of business development

and Bruce Zetter, of Harvard Medical School and Children’s Hospital in Boston. • Avigen Inc., of Alameda, Calif., appointed Alan McClelland vice president, research and development. • Axonyx Inc., of New York, retained Norman Lavy as senior consultant and adviser in pharmaceutical research, medical and regulatory affairs. • Cephalon Inc., of West Chester, Pa., promoted George McCormick to vice president, drug safety and disposition